Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia

Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez-Olivencia, German, Estébanez, Miriam, Membrillo, Francisco Javier, Ybarra, Maria del Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103312/
http://dx.doi.org/10.1016/j.eimc.2018.05.008
_version_ 1783512030737596416
author Ramírez-Olivencia, German
Estébanez, Miriam
Membrillo, Francisco Javier
Ybarra, Maria del Carmen
author_facet Ramírez-Olivencia, German
Estébanez, Miriam
Membrillo, Francisco Javier
Ybarra, Maria del Carmen
author_sort Ramírez-Olivencia, German
collection PubMed
description Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administration. We conducted a review of the indications of the main drug agencies (Spanish, European and American) and other possible indications, mainly haemorrhagic fevers and coronavirus.
format Online
Article
Text
id pubmed-7103312
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
record_format MEDLINE/PubMed
spelling pubmed-71033122020-03-31 Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia Ramírez-Olivencia, German Estébanez, Miriam Membrillo, Francisco Javier Ybarra, Maria del Carmen Enferm Infecc Microbiol Clin Article Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administration. We conducted a review of the indications of the main drug agencies (Spanish, European and American) and other possible indications, mainly haemorrhagic fevers and coronavirus. Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. 2019-11 2018-06-12 /pmc/articles/PMC7103312/ http://dx.doi.org/10.1016/j.eimc.2018.05.008 Text en © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ramírez-Olivencia, German
Estébanez, Miriam
Membrillo, Francisco Javier
Ybarra, Maria del Carmen
Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
title Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
title_full Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
title_fullStr Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
title_full_unstemmed Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
title_short Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
title_sort uso de ribavirina en virus distintos de la hepatitis c. una revisión de la evidencia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103312/
http://dx.doi.org/10.1016/j.eimc.2018.05.008
work_keys_str_mv AT ramirezolivenciagerman usoderibavirinaenvirusdistintosdelahepatitiscunarevisiondelaevidencia
AT estebanezmiriam usoderibavirinaenvirusdistintosdelahepatitiscunarevisiondelaevidencia
AT membrillofranciscojavier usoderibavirinaenvirusdistintosdelahepatitiscunarevisiondelaevidencia
AT ybarramariadelcarmen usoderibavirinaenvirusdistintosdelahepatitiscunarevisiondelaevidencia

Ejemplares similares